Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $138.1800 (0.39%) ($137.0800 - $139.1860) on Fri. Jun. 9, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.47% (three month average) | RSI | 33 | Latest Price | $138.1800(0.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.2% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) IBB(14%) XBI(12%) UUP(11%) XLU(11%) XOP(11%) | Factors Impacting ABBV price | ABBV will decline at least -0.735% in a week (0% probabilities). BWX(-17%) IPO(-14%) BNDX(-13%) XLC(-12%) CEMB(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.735% (StdDev 1.47%) | Hourly BBV | 0.7 () | Intraday Trend | 0.5% | | | |
|
Resistance Level | $139.93 | 5 Day Moving Average | $136.92(0.92%) | 10 Day Moving Average | $136.7(1.08%) | 20 Day Moving Average | $139.93(-1.25%) | To recent high | -16.2% | To recent low | 3.6% | Market Cap | $243.789b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |